Privia Health Group, Inc. financial data

Symbol
PRVA on Nasdaq
Location
Arlington, VA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 175% % -2.61%
Debt-to-equity 76% % 4.5%
Return On Equity 3% % 24%
Return On Assets 1% % 22%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 123,001,529 shares 2.5%
Common Stock, Shares, Outstanding 122,867,531 shares 2.4%
Entity Public Float $1,070,000,000 USD -51.36%
Common Stock, Value, Issued $1,229,000 USD 2.5%
Weighted Average Number of Shares Outstanding, Basic 122,768,890 shares 2.6%
Weighted Average Number of Shares Outstanding, Diluted 128,776,684 shares 2.4%

Income Statement

Label TTM Value / Value Unit Change %
Selling and Marketing Expense $27,149,000 USD 3.5%
General and Administrative Expense $143,306,000 USD 18%
Operating Income (Loss) $28,205,000 USD 114%
Nonoperating Income (Expense) $10,384,000 USD 4.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $38,589,000 USD 60%
Income Tax Expense (Benefit) $14,081,000 USD 39%
Net Income (Loss) Attributable to Parent $18,167,000 USD 42%
Earnings Per Share, Basic 0 USD/shares 17%
Earnings Per Share, Diluted 0 USD/shares 30%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $441,352,000 USD 4.6%
Accounts Receivable, after Allowance for Credit Loss, Current $499,041,000 USD 22%
Assets, Current $970,926,000 USD 14%
Deferred Income Tax Assets, Net $17,046,000 USD -38.17%
Property, Plant and Equipment, Net $662,000 USD -54.53%
Operating Lease, Right-of-Use Asset $5,671,000 USD 7.2%
Goodwill $172,215,000 USD 23%
Other Assets, Noncurrent $16,928,000 USD 13%
Assets $1,350,987,000 USD 18%
Accounts Payable, Current $10,216,000 USD 47%
Liabilities, Current $582,914,000 USD 22%
Operating Lease, Liability, Noncurrent $3,672,000 USD 2.1%
Other Liabilities, Noncurrent $1,640,000 USD 424%
Liabilities $588,226,000 USD 22%
Retained Earnings (Accumulated Deficit) $-165,461,000 USD 9.9%
Stockholders' Equity Attributable to Parent $709,124,000 USD 15%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $762,761,000 USD 15%
Liabilities and Equity $1,350,987,000 USD 18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-24,061,000 USD 27%
Net Cash Provided by (Used in) Financing Activities $2,243,000 USD 372%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Shares, Issued 122,867,531 shares 2.4%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $-21,818,000 USD 43%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $441,352,000 USD 4.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $0 USD
Deferred Tax Assets, Gross $36,378,000 USD -17.93%
Operating Lease, Liability $5,590,000 USD -32.56%
Depreciation $228,000 USD -22.45%
Lessee, Operating Lease, Liability, to be Paid $5,798,000 USD -33.22%
Property, Plant and Equipment, Gross $8,048,000 USD 0.26%
Operating Lease, Liability, Current $2,563,000 USD -0.66%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,762,000 USD -26.61%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,401,000 USD -17.32%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) $1,713,000 USD 98%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $208,000 USD -47.07%
Lessee, Operating Lease, Liability, to be Paid, Year Three $814,000 USD -53.8%
Deferred Tax Assets, Operating Loss Carryforwards $11,537,000 USD -47.73%
Lessee, Operating Lease, Liability, to be Paid, Year Four $399,000 USD -50.98%
Additional Paid in Capital $873,356,000 USD 9.5%
Amortization of Intangible Assets $8,310,000 USD 38%
Depreciation, Depletion and Amortization $9,082,000 USD 26%
Deferred Tax Assets, Net of Valuation Allowance $36,378,000 USD -17.93%
Share-based Payment Arrangement, Expense $70,895,000 USD 34%